Sign in
4

Changes in Ownership

Entrada Therapeutics, Inc. Filed Acc 0001689375-23-000050

Chief Medical Officer sold 26,710 shares at an average $14.76 ($394,219)

  • Chief Medical Officer acquired 26,710 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
KREHER NERISSA Chief Medical Officer 2023-08-02 Option exercise 10b5-1 +10,348 $2.10 $21,731 37,478 D: show line 1 in the form
KREHER NERISSA Chief Medical Officer 2023-08-02 Sale 10b5-1 −9,280 $15.09 $140,013 28,198 D: show line 2 in the form
KREHER NERISSA Chief Medical Officer 2023-08-02 Sale 10b5-1 −1,000 $16.01 $16,012 27,198 D: show line 3 in the form
KREHER NERISSA Chief Medical Officer 2023-08-02 Sale 10b5-1 −68 $16.82 $1,144 27,130 D: show line 4 in the form
KREHER NERISSA Chief Medical Officer 2023-08-03 Option exercise 10b5-1 +9,464 $2.10 $19,874 36,594 D: show line 5 in the form
KREHER NERISSA Chief Medical Officer 2023-08-03 Sale 10b5-1 −9,464 $14.74 $139,530 27,130 D: show line 6 in the form
KREHER NERISSA Chief Medical Officer 2023-08-04 Option exercise 10b5-1 +6,898 $2.10 $14,486 34,028 D: show line 7 in the form
KREHER NERISSA Chief Medical Officer 2023-08-04 Sale 10b5-1 −6,898 $14.14 $97,521 27,130 D: show line 8 in the form
Open-market sales · 26,710 sh · avg $14.76 · $394,219

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
KREHER NERISSA Chief Medical Officer 2023-08-02 Option exercise · Stock Option (Right to Buy) 10b5-1 −10,348 104,374 D: show line 9 in the form
KREHER NERISSA Chief Medical Officer 2023-08-03 Option exercise · Stock Option (Right to Buy) 10b5-1 −9,464 94,910 D: show line 10 in the form
KREHER NERISSA Chief Medical Officer 2023-08-04 Option exercise · Stock Option (Right to Buy) 10b5-1 −6,898 88,012 D: show line 11 in the form
Loading xslF345X05/wf-form4_169118219238022.xml…